Is CUE or CURX more undervalued in 2026?

CirclFi compares Cue Biopharma, Inc. (CUE) and Curanex Pharmaceuticals Inc (CURX) using 13 institutional-grade valuation models. CUE has a Quality of Company score of 5.6/10 while CURX scores 4.4/10.

Which is a better buy — CUE or CURX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CUE and CURX valuations compare?

CUE at $22.64 and CURX at $0.34 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CUE vs CURX Valuation Comparison 2026 — Intrinsic Value Analysis

CUE

Biotechnology

Cue Biopharma, Inc.

Quality

5.6

out of 10

Value Trap

LOW

Price

$22.64

Last close

Models

9/13

Active

CURX

Biotechnology

Curanex Pharmaceuticals Inc

Quality

4.4

out of 10

Value Trap

—

Price

$0.34

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	CUE Fair Value	CUE Upside	CURX Fair Value	CURX Upside
Bayesian DCF	Intrinsic	$7.89	-65.1%	$0.16	-52.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.37	-98.8%	$0.05	-87.7%
Dynamic NAV	Asset-Based	$16.78	-25.9%	$0.29	-14.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CUE vs CURX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CUE vs CURX — Which Stock Is More Undervalued?

CUE scores higher with a 5.6/10 quality rating vs CURX's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cue Biopharma, Inc. (CUE) and Curanex Pharmaceuticals Inc (CURX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CUE currently trades at $22.64 with a QOC of 5.6/10, while CURX trades at $0.34 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).